Literature DB >> 33519244

Statistical Joint Modeling for Predicting the Association of CD4 Measurement and Time to Death of People Living with HIV Who Enrolled in ART, Southwest Ethiopia.

Firew Tiruneh1, Lalisa Chewaka2, Dinaol Abdissa1,3.   

Abstract

BACKGROUND: In much epidemiological HIV research, patients are often followed over a period of time to predict their survival on the basis of repeatedly measured CD4 status. To predict survival, statistical models of the association between mortality and longitudinal CD4 measurement have been conducted widely using time-varying Cox models. However, in the presence of repeated measure, this approach leads to biased estimates. In view of the limitation of time-varying Cox models, in the present study, we considered joint modeling to predict the association of longitudinal CD4 measurement and time to death among patients initiated on ART.
METHODS: A retrospective cohort study was employed for five years from 2009 to 2014 on a randomly selected 358 samples. Data were collected from patients' ART and pre-ART follow-up registration book, database and other clinical records. Data were analyzed using joint latent class modeling of repeated CD4 measurement and time-to-event (HIV death).
RESULTS: We have studied a total of 358 HIV-positive patients. The median and interquartile ranges of the age of patients were 30.31 years and 13.82, respectively. Males constitute the larger proportion, 51.68%. The square root of CD4 count has declined on average over time. This has been indicated with the negative sign of the coefficient for the time effect. The deterioration of health of individuals is severe in class 1, it has been observed with a worse decline in CD4 cell counts over time in this class than other classes (β= -0.488). Women had a larger risk rate than men (β=-2.475, p-value=0.013). Besides, the CD4 counts measurement of patients has been revealed to decrease as age increases (β= -0.016, p=0.008).
CONCLUSION: The finding indicated that the square root CD4 cell measurement dropped over time in the three classes. This clearly suggested deterioration in the health of individuals. Women were found to have a higher hazard rate than men.
© 2021 Tiruneh et al.

Entities:  

Keywords:  CD4; HIV; joint modeling; prediction; survival

Year:  2021        PMID: 33519244      PMCID: PMC7837561          DOI: 10.2147/HIV.S283059

Source DB:  PubMed          Journal:  HIV AIDS (Auckl)        ISSN: 1179-1373


  20 in total

1.  The impact of highly active antiretroviral therapy on the survival of vertically HIV-infected children and adolescents in Belo Horizonte, Brazil.

Authors:  Claudete Aparecida Araújo Cardoso; Jorge A Pinto; Talitah Michel Sanchez Candiani; Inácio Roberto de Carvalho; Renato Moreira Linhares; Eugênio Marcos Andrade Goulart
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-06       Impact factor: 2.743

2.  Joint modelling of longitudinal measurements and event time data.

Authors:  R Henderson; P Diggle; A Dobson
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

3.  A latent class mixed model for analysing biomarker trajectories with irregularly scheduled observations.

Authors:  H Lin; C E McCulloch; B W Turnbull; E H Slate; L C Clark
Journal:  Stat Med       Date:  2000-05-30       Impact factor: 2.373

4.  Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia.

Authors:  Andinet Worku Alemu; Miguel San Sebastián
Journal:  Glob Health Action       Date:  2010-10-29       Impact factor: 2.640

5.  Survival status of hiv positive adults on antiretroviral treatment in Debre Markos Referral Hospital, Northwest Ethiopia: retrospective cohort study.

Authors:  Nurilign Abebe; Kassahun Alemu; Tadese Asfaw; Amanuel Alemu Abajobir
Journal:  Pan Afr Med J       Date:  2014-02-03

6.  Research on AIDS patients' survival time after highly active antiretroviral therapy, treatment effect and treatment modes.

Authors:  Riying Lv; Guojian Li; Jizhou Wu; Yujia Zhu; Xionglin Qin; Shixiong Li
Journal:  Saudi Pharm J       Date:  2016-04-26       Impact factor: 4.330

7.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.

Authors: 
Journal:  Lancet HIV       Date:  2017-05-10       Impact factor: 12.767

8.  Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study.

Authors:  Erdaw Tachbele; Gobena Ameni
Journal:  Epidemiol Health       Date:  2016-11-06

9.  Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.

Authors:  Margaret T May; Jorg-Janne Vehreschild; Adam Trickey; Niels Obel; Peter Reiss; Fabrice Bonnet; Murielle Mary-Krause; Hasina Samji; Matthias Cavassini; Michael John Gill; Leah C Shepherd; Heidi M Crane; Antonella d'Arminio Monforte; Greer A Burkholder; Margaret M Johnson; Paz Sobrino-Vegas; Pere Domingo; Robert Zangerle; Amy C Justice; Timothy R Sterling; José M Miró; Jonathan A C Sterne; Andrew Boulle; Christoph Stephan; Jose M Miro; Matthias Cavassini; Geneviève Chêne; Dominique Costagliola; François Dabis; Antonella D'Arminio Monforte; Julia Del Amo; Ard Van Sighem; Gerd Fätkenheuer; John Gill; Jodie Guest; David Hans-Ulrich Haerry; Robert Hogg; Amy Justice; Leah Shepherd; Neils Obel; Heidi Crane; Colette Smith; Peter Reiss; Michael Saag; Tim Sterling; Ramon Teira; Matthew Williams; Robert Zangerle; Jonathan Sterne; Margaret May; Suzanne Ingle; Adam Trickey
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

Review 10.  Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review.

Authors:  Mohammed Biset Ayalew
Journal:  AIDS Res Treat       Date:  2017-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.